SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Multiple Sclerosis
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
1352458507077403v1
13/7/939    most recent
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Saito, H.
Right arrow Articles by Kato, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saito, H.
Right arrow Articles by Kato, S.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Retinopathy in a multiple sclerosis patient undergoing interferon-therapy

Hitomi Saito

Department of Ophthalmology, University of Tokyo, Graduate School of Medicine, Tokyo, Japan, hitomi8678{at}yahoo.co.jp

Mariko Suzuki

Department of Ophthalmology, University of Tokyo, Graduate School of Medicine, Tokyo, Japan

Takehiro Asakawa

Department of Neurology, University of Tokyo, Graduate School of Medicine, Tokyo, Japan

Satoshi Kato

Department of Ophthalmology, University of Tokyo, Graduate School of Medicine, Tokyo, Japan

A 30-year old male developed retinopathy, with flame-shaped retinal hemorrhages and soft exudates in both eyes, while receiving interferon-ß injections as a preventive therapy for multiple sclerosis (MS). After discontinuing interferon injections upon presentation of the retinopathy, the retinopathy subsided without specific therapy. Visual acuity remained stable throughout the course of observation. Though assumed to be related to interferon therapy, the ocular findings of retinopathy disappeared without specific treatment. This clinical course of retinopathy is very similar to the interferon-induced retinopathy observed in type C hepatitis patients, but there are far fewer reports on MS-related interferon retinopathy. Multiple Sclerosis 2007; 13: 939—940. http://msj.sagepub.com

Key Words: interferon • retinopathy • multiple sclerosis • type-C hepatitis

This version was published on August 1, 2007

Multiple Sclerosis, Vol. 13, No. 7, 939-940 (2007)
DOI: 10.1177/1352458507077403
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement